Save the date: Calliditas to host Capital Markets Day in Stockholm on November 4, 2019
Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that the company will host a Capital Markets Day in Stockholm on November 4, 2019, for investors, analysts and media.Presentations will be made by members of Calliditas’ management and external authorities in IgA nephropathy and orphan liver diseases. The program includes an overview of the company's operations and strategy with deeper descriptions of the key projects, the company's external collaborations and the regulatory path towards market approval. Furthermore, an overview is made of the commercial potential of the